Tianjin Zhongxin Pharmaceutical Group

Broker's Calls

Tianjin ZhongXin Pharma poised for turnaround: UOB

SINGAPORE (Jan 10): Tianjin ZhongXin Pharmaceutical Group is poised for a major turnaround, says UOB Kay Hian.

Broker's Calls

Despite lacklusture topline, this S-chip’s FY16 performance shone in more ways than one

SINGAPORE (April 5): CIMB Research is maintaining its “add” recommendation on Tianjin Zhongxin Pharmaceutical Group with an unchanged target price of US$1.30 ($1.82) as it continues to like the S-share as a “cheap proxy for China’s growing pharmac

Hot Stock

Tianjin Zhongxin Pharmaceutical up 5% on back of higher trading volume

SINGAPORE (Nov 23): Shares of Tianjin Zhongxin Pharmaceutical Group closed 5% higher at 84 US cents on Tuesday.

In print this week

Is Tianjin Zhongxin the next China New Town Development?

SINGAPORE (Nov 18): Last month, township developer China New Town Development Co made a conditional cash exit offer of seven cents a share to holders of its Singapore-listed shares by way of a selective share buyback.
×